ViroGates A/S (OCSE:VIRO) Institutional Ownership : 0.32% (As of May. 22, 2024)

View and export this data going back to 2018. Start your Free Trial

What is ViroGates A/S Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ViroGates A/S's institutional ownership is 0.32%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ViroGates A/S's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ViroGates A/S's Float Percentage Of Total Shares Outstanding is 0.00%.

ViroGates A/S Institutional Ownership Historical Data

The historical data trend for ViroGates A/S's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates A/S Institutional Ownership Chart

ViroGates A/S Historical Data

The historical data trend for ViroGates A/S can be seen below:

	2022-02-28	2022-03-31	2022-04-30	2022-05-31	2022-06-30	2022-07-31	2022-08-31	2022-09-30
Institutional Ownership	0.32	0.32	0.32	0.34	0.34	0.32	0.32	0.32

ViroGates A/S Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

ViroGates A/S (OCSE:VIRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates A/S (OCSE:VIRO) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

Banevaenget 13, Birkerod, DNK, DK-3460

Website

https://www.virogates.com

ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates A/S (OCSE:VIRO) Headlines

No Headlines